Device
Transcutaneous non-invasive vagus nerve stimulation (tVNS)
Transcutaneous non-invasive vagus nerve stimulation (tVNS) is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Enrolling by invitation2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
enrolling_by_invitation267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
tVNS, Motivation, and Insulin Sensitivity
NCT07198100
enrolling_by_invitationnot_applicable
tVNS and Obesity-related Mechanisms
NCT06954844
enrolling_by_invitationnot_applicable
Non-invasive Vagus Nerve Stimulation as a Tool to Modulate Stomach-Brain Coupling in Depression
NCT06389175
Clinical Trials (3)
Showing 3 of 3 trials
NCT07198100Not Applicable
tVNS, Motivation, and Insulin Sensitivity
NCT06954844Not Applicable
tVNS and Obesity-related Mechanisms
NCT06389175Not Applicable
Non-invasive Vagus Nerve Stimulation as a Tool to Modulate Stomach-Brain Coupling in Depression
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3